Expression of PKM2 in wound keratinocytes is coupled to angiogenesis during skin repair in vivo and in HaCaT keratinocytes in vitro.


Journal

Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370

Informations de publication

Date de publication:
02 2023
Historique:
received: 15 03 2022
accepted: 09 12 2022
revised: 08 12 2022
pubmed: 13 1 2023
medline: 4 3 2023
entrez: 12 1 2023
Statut: ppublish

Résumé

An injured skin is rapidly restored in a manner of wound healing. We have previously shown that intact insulin signaling and glucose uptake are fundamental to proper wound closure. Consequently, under exacerbated inflammation, compromised insulin action and glucose uptake lead to impaired healing. However, in spite of the increased attention to cell metabolism during tissue regeneration, metabolic mediators that govern cellular and physiological processes throughout skin repair remained largely elusive. Through assessment of mRNA using real-time PCR and protein blot analysis, we report that healing of cutaneous wounds comprise a boosted expression of genes involved in glycolysis, oxidative phosphorylation, pentose phosphate shunt, and glutamine anaplerosis. We further focused on the functional role of pyruvate kinase M (PKM) isoenzymes that catalyze the final and rate-limiting step of glycolysis. Whereas the expression of the metabolic constitutively active Pkm1 isozyme remained almost unchanged, Pkm2 is augmented during the inflammatory phase of healing. The immunohistochemistry and RNA in situ hybridization analysis showed a confined Pkm2 expression to keratinocytes of the hyperproliferative epithelium and, to a lesser extent, infiltrating neutrophils and monocytes as well as later on in macrophages. Notably, the expression of Pkm2 in keratinocytes facing the wound bed side colocalized with VEGF expression. The in vitro knockdown of PKM2 in HaCaT keratinocytes using small interfering (si) RNA confirmed an acute role for PKM2 in facilitating the complete induction of VEGF mRNA and protein expression in keratinocytes; this function is mainly HIF-1α independent. KEY MESSAGES: • Wound healing involves activation of glycolysis, oxidative phosphorylation, pentos-phosphate shunt, and replenishment of tri-carboxylic acid (TCA) cycle through glutamine anaplerosis. • The pyruvate kinase M2 (PKM2) isoform is upregulated during the inflammatory phase of cutaneous healing, mainly in keratinocytes of hyperproliferative epithelia. • In vivo, the expression of VEGF in wound keratinocytes is colocalized with PKM2. • PKM2 is required for full induction of VEGF in HaCaT keratinocytes in vitro.

Identifiants

pubmed: 36633604
doi: 10.1007/s00109-022-02280-6
pii: 10.1007/s00109-022-02280-6
pmc: PMC9977898
doi:

Substances chimiques

Glucose IY9XDZ35W2
Glutamine 0RH81L854J
Insulins 0
Pyruvate Kinase EC 2.7.1.40
RNA 63231-63-0
RNA, Messenger 0
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-169

Informations de copyright

© 2022. The Author(s).

Références

Am J Pathol. 2009 Jul;175(1):132-47
pubmed: 19528348
Science. 2017 May 5;356(6337):513-519
pubmed: 28473584
Biochemistry. 2005 Jul 12;44(27):9417-29
pubmed: 15996096
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
J Invest Dermatol. 2006 Feb;126(2):477-85
pubmed: 16374465
Cell Res. 2012 Mar;22(3):447-9
pubmed: 22184007
Cell Metab. 2020 Feb 4;31(2):391-405.e8
pubmed: 31761564
Cell. 2013 Oct 10;155(2):397-409
pubmed: 24120138
J Exp Med. 2020 Oct 5;217(10):
pubmed: 32697823
Trends Cell Biol. 2005 Nov;15(11):599-607
pubmed: 16202600
Front Immunol. 2014 Sep 02;5:420
pubmed: 25228902
Sci Signal. 2009 Nov 17;2(97):ra73
pubmed: 19920251
Cancer Metab. 2018 May 31;6:6
pubmed: 29854399
Cell Cycle. 2013 Oct 1;12(19):3154-8
pubmed: 24013426
J Cell Biol. 1988 Mar;106(3):761-71
pubmed: 2450098
Immunol Cell Biol. 2019 Mar;97(3):268-278
pubmed: 30779212
Mediators Inflamm. 2015;2015:607363
pubmed: 26136626
Int Wound J. 2017 Feb;14(1):53-63
pubmed: 26678712
Science. 2017 Jun 9;356(6342):1026-1030
pubmed: 28596335
Cancer Cell. 2005 Jan;7(1):77-85
pubmed: 15652751
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Oncotarget. 2011 Jul;2(7):551-6
pubmed: 21709315
Cell Cycle. 2010 Nov 1;9(21):4253
pubmed: 21045562
J Invest Dermatol. 2009 Mar;129(3):752-64
pubmed: 18668138
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Nature. 2008 Mar 13;452(7184):181-6
pubmed: 18337815
Annu Rev Immunol. 2011;29:415-45
pubmed: 21219177
Wound Repair Regen. 2016 Mar;24(2):328-36
pubmed: 26808610
J Biol Chem. 1987 Oct 15;262(29):14366-71
pubmed: 3654663
Nat Chem Biol. 2012 Oct;8(10):839-47
pubmed: 22922757
Physiol Rev. 2019 Jan 1;99(1):665-706
pubmed: 30475656
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
pubmed: 18032601
N Engl J Med. 1986 Dec 25;315(26):1650-9
pubmed: 3537791
J Invest Dermatol. 2009 Mar;129(3):529-31
pubmed: 19209152
N Engl J Med. 1999 Sep 2;341(10):738-46
pubmed: 10471461
Cancer Metab. 2018 Oct 23;6:17
pubmed: 30386596
Mol Cell. 2015 Aug 6;59(3):359-71
pubmed: 26190262
J Biol Chem. 1995 May 26;270(21):12607-13
pubmed: 7759509
Nature. 2012 Nov 15;491(7424):458-462
pubmed: 23064226
Mol Cell. 2015 Sep 3;59(5):850-7
pubmed: 26300261
Cell Metab. 2015 Feb 3;21(2):347
pubmed: 29510100
J Invest Dermatol. 2007 Sep;127(9):2259-67
pubmed: 17460730
Annu Rev Immunol. 2014;32:609-34
pubmed: 24655299
Am J Pathol. 2006 Mar;168(3):765-77
pubmed: 16507892
Front Immunol. 2021 Jan 19;11:595316
pubmed: 33542713
Cell. 2017 May 4;169(4):570-586
pubmed: 28475890
Biochim Biophys Acta. 2008 Feb;1783(2):323-33
pubmed: 18166158
Cell. 2011 May 27;145(5):732-44
pubmed: 21620138
Free Radic Biol Med. 2019 Nov 1;143:176-192
pubmed: 31401304
Science. 2010 Sep 17;329(5998):1492-9
pubmed: 20847263
Nat Cell Biol. 2012 Dec;14(12):1295-304
pubmed: 23178880
PLoS One. 2016 Dec 19;11(12):e0168562
pubmed: 27992530
J Cell Sci. 2008 Sep 15;121(Pt 18):2992-3001
pubmed: 18713836
J Biol Chem. 1986 Oct 15;261(29):13807-12
pubmed: 3020052
Mol Pharmacol. 2008 Oct;74(4):952-63
pubmed: 18599600
FEBS J. 2022 Sep 9;:
pubmed: 36083715
Cell Biosci. 2014 Apr 15;4:20
pubmed: 24735734
J Exp Med. 2012 Feb 13;209(2):217-24
pubmed: 22271574
FASEB J. 1999 Nov;13(14):2002-14
pubmed: 10544183
Mol Cell. 2012 Mar 9;45(5):598-609
pubmed: 22306293
PLoS Comput Biol. 2011 Mar;7(3):e1002018
pubmed: 21423717
J Invest Dermatol. 1999 Dec;113(6):1090-8
pubmed: 10594757
EMBO Rep. 2016 Dec;17(12):1721-1730
pubmed: 27856534
Physiol Rev. 2003 Jul;83(3):835-70
pubmed: 12843410
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Nat Protoc. 2006;1(1):418-28
pubmed: 17406264
Anal Biochem. 1987 Apr;162(1):156-9
pubmed: 2440339

Auteurs

Khrystyna Sych (K)

Pharmazentrum Frankfurt/ZAFES, General Pharmacology and Toxicology, Faculty of Medicine, Goethe-University, Frankfurt, Frankfurt am Main, Germany.

Simon P Nold (SP)

Pharmazentrum Frankfurt/ZAFES, General Pharmacology and Toxicology, Faculty of Medicine, Goethe-University, Frankfurt, Frankfurt am Main, Germany.

Josef Pfeilschifter (J)

Pharmazentrum Frankfurt/ZAFES, General Pharmacology and Toxicology, Faculty of Medicine, Goethe-University, Frankfurt, Frankfurt am Main, Germany.

Rajkumar Vutukuri (R)

Pharmazentrum Frankfurt/ZAFES, General Pharmacology and Toxicology, Faculty of Medicine, Goethe-University, Frankfurt, Frankfurt am Main, Germany.

Jana Meisterknecht (J)

Functional Proteomics, Institute for Cardiovascular Physiology, Goethe-University, Frankfurt, Theodor-Stern-Kai 7, D-60590, Frankfurt, Frankfurt am Main, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt am Main, Germany.

Ilka Wittig (I)

Functional Proteomics, Institute for Cardiovascular Physiology, Goethe-University, Frankfurt, Theodor-Stern-Kai 7, D-60590, Frankfurt, Frankfurt am Main, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt am Main, Germany.

Stefan Frank (S)

Pharmazentrum Frankfurt/ZAFES, General Pharmacology and Toxicology, Faculty of Medicine, Goethe-University, Frankfurt, Frankfurt am Main, Germany.

Itamar Goren (I)

Pharmazentrum Frankfurt/ZAFES, General Pharmacology and Toxicology, Faculty of Medicine, Goethe-University, Frankfurt, Frankfurt am Main, Germany. goren@chemie.uni-frankfurt.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH